Rubella vaccine, live-attenuated (Dalian Jingang Andi)

风疹减毒活疫苗(人二倍体细胞)（大连金港安迪）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRubella vaccine, live-attenuated (Dalian Jingang Andi)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsRubella

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusDiscontinued (IND)

Highest Status in ChinaDiscontinued

Originator CompaniesDalian Jingang Andi Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesDalian Jingang Andi Biological Products Co Ltd

Active IndicationsN/A

Inactive IndicationsRubella

Other Information

ATC CodeN/A